CVKD
Cadrenal Therapeutics, Inc. · Healthcare · Market cap $4.0M(Price slightly stale)
Insiders sold $388K net in the last 90 days ·1 seller, 0 buyers· 22 of 22 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 2, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$542K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Jul 2, 2026
Pham Quang X
Cadrenal Therapeutics, Inc. (CVKD) has 13 SEC Form 4 filings (27 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.
Inside the rolling window, 2 insiders at Cadrenal Therapeutics, Inc. reported no open-market purchases and 27 open-market sales totaling $542K. The most active filer is Chairman and CEO Pham Quang X with 24 filings. Insiders have net sold $388K over the trailing 6 months. The most recent open-market filing is a sale of 7,400 shares by Chairman and CEO Pham Quang X, dated Jun 29, 2026, worth $22K.
- Industry:Biotechnology
- CEO:Quang X. Pham
- Employees:5
- HQ:Ponte Vedra, FL, US
- IPO:2023-01-20
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chairman and CEO | Sale | 7,400 | $22K | Jul 2 | -68.9% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 2,127 | $6K | Jun 27 | -62.9% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 9,029 | $28K | Jun 27 | -62.9% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 9,167 | $33K | Jun 24 | -62.4% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 2,277 | $7K | Jun 24 | -62.4% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,613 | $11K | Jun 18 | -68.0% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 513 | $2K | Jun 18 | -68.0% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 1,462 | $6K | Jun 16 | -63.2% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 12,996 | $51K | Jun 16 | -63.2% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,666 | $13K | Jun 16 | -63.2% | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 5,893 | $26K | Jun 11 | — | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 12,992 | $53K | Jun 11 | — | SEC ↗ | |
| Chairman, CEO and Interim CFO | Sale | 3,500 | $15K | Jun 11 | — | SEC ↗ | |
| CEO and Chairman | Sale | 2,323 | $10K | Jun 5 | — | SEC ↗ | |
| CEO and Chairman | Sale | 3,898 | $17K | Jun 5 | — | SEC ↗ | |
| CEO and Chairman | Sale | 2,064 | $9K | Jun 5 | — | SEC ↗ | |
| CEO and Chairman | Sale | 303 | $2K | Jun 3 | — | SEC ↗ | |
| CEO and Chairman | Sale | 349 | $2K | Jun 3 | — | SEC ↗ | |
| CEO and Chairman | Sale | 6,476 | $37K | May 29 | — | SEC ↗ | |
| CEO and Chairman | Sale | 3,298 | $17K | May 29 | — | SEC ↗ | |
| CEO and Chairman | Sale | 2,989 | $15K | May 29 | — | SEC ↗ | |
Pham Quang XFirst in 7 months | CEO and Chairman | Sale | 1,165 | $7K | May 27 | — | SEC ↗ |
| Chief Financial Officer | Sale | 9,933 | $69K | Dec 31 | — | SEC ↗ | |
Pham Quang XFirst filing | CEO and Chairman | Sale | 1,129 | $16K | Oct 28 | — | SEC ↗ |
Pham Quang XFirst filing | CEO and Chairman | Sale | 1,315 | $18K | Oct 28 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does CVKD have?
Cadrenal Therapeutics, Inc. (CVKD) has 13 SEC Form 4 filings (27 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Jul 2, 2026.
When was the most recent SEC Form 4 filing for CVKD?
The most recent Form 4 filing for CVKD on Tracefour is dated Jul 2, 2026.
Who is the most active insider at CVKD?
The most active SEC Form 4 filer at CVKD in the rolling window is Chairman and CEO Pham Quang X, with 24 filings.
What is the net insider flow at CVKD over the last 6 months?
Over the trailing 180 days, insiders at CVKD have net sold $388K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CVKD in the current window?
Inside the rolling window, insiders at CVKD bought $0 and sold $542K based on SEC Form 4 filings.
Can I get alerts for CVKD insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Cadrenal Therapeutics, Inc. (CVKD). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Cadrenal Therapeutics, Inc. is in the Healthcare sector.